Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K D Lindor

Showing results (11-20 of 142) with videos related to

Pageof 15
Sort By:
Hepatology (Baltimore, Md.)|September 26, 2000
Medical treatment for primary sclerosing cholangitis: risk versus benefitP Angulo, K D Lindor
Journal of Clinical Gastroenterology|December 29, 2000
Primary sclerosing cholangitis: emerging new promising therapiesP Angulo, K D Lindor
Seminars in Liver Disease|April 12, 2001
Treatment of nonalcoholic fatty liver: present and emerging therapiesP Angulo, K D Lindor
Gastroenterology|July 1, 1991
Ursodeoxycholic acid for the treatment of home parenteral nutrition-associated cholestasis. A case reportK D Lindor, J Burnes
Clinics in Liver Disease|November 25, 2004
Management of primary biliary cirrhosis and autoimmune cholangitisP Angulo, K D Lindor
Hepatology (Baltimore, Md.)|July 1, 1999
Primary sclerosing cholangitisP Angulo, K D Lindor
Gastroenterology|March 27, 2001
Insulin resistance and mitochondrial abnormalities in NASH: a cool look into a burning issueP Angulo, K D Lindor
Alimentary Pharmacology & Therapeutics|March 26, 2018
Editorial: is proton pump inhibitor use associated with worse outcomes in patients with liver abscesses?J H Tabibian, K D Lindor
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|December 8, 2000
Medical management of chronic cholestatic liver diseasesA A Gossard, K D Lindor
Digestive Diseases (Basel, Switzerland)|November 1, 1994
Primary biliary cirrhosisJ M Laurin, K D Lindor
Pageof 15

Showing results (11-20 of 142) with videos related to

Sort By:
Pageof 15
Hepatology (Baltimore, Md.)|September 26, 2000
Medical treatment for primary sclerosing cholangitis: risk versus benefitP Angulo, K D Lindor
Journal of Clinical Gastroenterology|December 29, 2000
Primary sclerosing cholangitis: emerging new promising therapiesP Angulo, K D Lindor
Seminars in Liver Disease|April 12, 2001
Treatment of nonalcoholic fatty liver: present and emerging therapiesP Angulo, K D Lindor
Gastroenterology|July 1, 1991
Ursodeoxycholic acid for the treatment of home parenteral nutrition-associated cholestasis. A case reportK D Lindor, J Burnes
Clinics in Liver Disease|November 25, 2004
Management of primary biliary cirrhosis and autoimmune cholangitisP Angulo, K D Lindor
Hepatology (Baltimore, Md.)|July 1, 1999
Primary sclerosing cholangitisP Angulo, K D Lindor
Gastroenterology|March 27, 2001
Insulin resistance and mitochondrial abnormalities in NASH: a cool look into a burning issueP Angulo, K D Lindor
Alimentary Pharmacology & Therapeutics|March 26, 2018
Editorial: is proton pump inhibitor use associated with worse outcomes in patients with liver abscesses?J H Tabibian, K D Lindor
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|December 8, 2000
Medical management of chronic cholestatic liver diseasesA A Gossard, K D Lindor
Digestive Diseases (Basel, Switzerland)|November 1, 1994
Primary biliary cirrhosisJ M Laurin, K D Lindor
Pageof 15